Brief: Zafgen enters into subscription agreement with Chong Kun Dang Pharmaceutical Corp - SEC filing
Nov 21 (Reuters) - Zafgen Inc ZFGN.O : * On November 20, 2014, co entered into a subscription agreement with chong kun dang pharmaceutical corporation - SEC filing * Zafgen issued to CKD 171,750 shares of its restricted common stock in lieu of a cash payment of $3.3 million * Cash payment represents 50% of $6.5 million milestone payments payable to ckd * Source text for Eikon (http://1.usa.gov/1uLQNu7) * Further company coverage ZFGN.O ((Bangalore Newsroom; +1 646 223 8780))
Recent news on Chong Kun Dang Pharmaceutical
See all newsBrief: Chong Kun Dang Pharmaceutical Corp To Invest 392.5 Billion Won In Research Centre And Other Facility
Brief: Chong Kun Dang Pharmaceutical Q1 Operating Profit 17.6 Billion Won, Up 37% From Year Earlier
Brief: Chong Kun Dang Pharmaceutical Q3 Operating Profit 20.5 Billion Won, Down 19% From Year Earlier
Brief: Chong Kun Dang Pharmaceutical To Divest 61 Billion Won Worth Of Own Shares
Brief: Chong Kun Dang Pharmaceutical Q1 Operating Profit 12.8 Billion Won, Down 52% From Year Earlier